Clinical trial
HS-IT101 Injection for Advanced NSCLC
NCT07105176
Study timeline
Study start (estimated)2025-08-30Date precision: day
Registry last updated2025-08-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Non-Small Cell Lung Cancerunresolved
Interventions
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
FludarabineDRUG · verified · RxNorm: fludarabine
Sponsors & collaborators
Hangzhou Huasai Biomedicine Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07105176 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.